showed a trendP = 0.06
In contrast, subjects receiving treatment with Cat‐PAD showed a trend toward downregulation of CRTh2 ( P = 0.06) which was significant when comparing the change in MFI between subjects in the placebo vs active group ( P = 0.047) (Figure 5 ). 4.